Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9230312 | Journal of Investigative Dermatology | 2005 | 8 Pages |
Abstract
Mice deficient in the CD4 molecule (CD4â/â) are widely used to evaluate the requirement for CD4+ T cell help in viral, tumoral, and transplantation immunity. Previous studies, showing that CD4â/â mice develop impaired contact hypersensitivity (CHS) responses, have suggested that CD4+ T cells are required for the optimal induction of this skin inflammatory reaction. other studies have, however, demonstrated that CHS was mediated by CD8+ T cells, without the need for CD4+ T cell help. Here, we show that CD4â/â mice develop a normal delayed-type hypersensitivity response to protein antigen, which is mediated by major histocompatibility molecules class II-restricted CD4-CD8- T cells, but a decreased CHS response to 2,4-dinitro-fluorobenezene. Analysis of the hapten-specific T cell pool demonstrates that priming of CD8+ T cells occurred normally in CD4â/â mice, as assessed by specific proliferative responses and interferon-γ (IFN-γ) production of purified CD8+ T cells. Furthermore, CD8+ T cells were able to adoptively transfer a normal CHS reaction. In contrast, total lymph node cells from CD4â/â mice showed decreased IFN-γ production and diminished specific cytotoxic T lymphocytes (CTL) activity, which could be reversed by in vitro restimulation with hapten-pulsed class II-deficient antigen-presenting cells. These data confirm that class I-restricted CD8+ T cells can fully develop in effectors of CHS in the absence of CD4+ T cell help and suggest that the impaired CHS in CD4â/â mice is because of the presence of a class II-restricted T cell subset, which controls CHS by inhibiting hapten-specific CTL responses.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Pierre Saint-Mezard, Cyril Chavagnac, Marc Vocanson, Jeanne Kehren, Aurore Rozières, Sophie Bosset, Marius Ionescu, Bertrand Dubois, Dominique Kaiserlian, Jean-Francois Nicolas, Frédéric Bérard,